» Articles » PMID: 15616892

Multiple Vertebral Fractures Are Associated with Refractory Reflux Esophagitis in Postmenopausal Women

Overview
Specialty Endocrinology
Date 2004 Dec 24
PMID 15616892
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

We examined the frequency of multiple vertebral fractures (MVFs) and esophageal hiatal hernia (HH) in 18 Japanese postmenopausal women (74.1 +/- 9.9 years, mean +/- SD), with refractory reflux esophagitis (RRE) that had needed a proton pump inhibitor for more than 6 months to suppress symptoms such as heartburn and acid regurgitation, as well as in 57 control subjects without RE (71.4 +/- 5.9 years). MVFs (two or more VFs), HH, and both features were found in 11 (61%), 16 (89%), and 11 (61%) subjects, respectively, in the RRE group. All 11 patients with MVFs also had HH, suggesting their strong association. On the other hand, MVFs, HH, and both were found in 15 (26%), 23 (40%), and 8 (14%) subjects, respectively, in those without RE. The differences in frequencies of MVFs, HH, and both between the two groups were significant (chi2 = 7.3, 12.9, and 16.0; P = 0.015, 0.0009, and 0.0002, respectively). When univariate logistic regression analysis was performed with the presence of RRE as a dependent variable and the presence of MVFs, HH, and both as independent variables, MVFs, HH, and both were selected as indices affecting the presence of RRE (age-adjusted odds ratios: 4.34, 11.07, and 10.30; 95% confidential intervals: 1.40-13.45, 2.30-53.22, and 2.96-35.86; P = 0.0109, 0.0027, and 0.0002, respectively). These results show that the presence of MVFs is associated with the presence of RRE in Japanese postmenopausal women, and this association becomes more significant when HH is present. Thus, a kyphotic lumbar spine with MVFs may cause HH and RE by raising the intraabdominal pressure. As recent therapeutic agents for osteoporosis, alendronate and risedronate, are known to be very effective for suppressing the occurrence of new VFs, these agents may also prevent gastrointestinal disorders such as HH and RRE in osteoporotic women when administered to subjects without VFs.

Citing Articles

Effect of long-term proton pump inhibitors on phosphocalcium metabolism and bone mineral density.

Smaoui H, Chtourou L, Jallouli D, Jemaa S, Karaa I, Boudabbous M Future Sci OA. 2024; 10(1):FSO977.

PMID: 38841182 PMC: 11152587. DOI: 10.2144/fsoa-2023-0198.


Comparison of the Clinical Efficacy of Anabolic Agents and Bisphosphonates in the Patients With Osteoporotic Vertebral Fracture: Systematic Review and Meta-analysis of Randomized Controlled Trials.

Jeon I, Park S, Moon B, Choi M, Kuh S, Kim J Neurospine. 2024; 21(2):416-429.

PMID: 38697911 PMC: 11224729. DOI: 10.14245/ns.2347256.628.


Clinicopathological and genomic features of superficial esophageal squamous cell carcinomas in nondrinker, nonsmoker females.

Fukuhara M, Urabe Y, Nakahara H, Ishikawa A, Ishibashi K, Konishi H Cancer Med. 2024; 13(4):e7078.

PMID: 38457229 PMC: 10923044. DOI: 10.1002/cam4.7078.


Increase in lumbar kyphosis and spinal inclination, declining back muscle strength, and sarcopenia are risk factors for onset of GERD: a 5-year prospective longitudinal cohort study.

Imagama S, Ando K, Kobayashi K, Machino M, Tanaka S, Morozumi M Eur Spine J. 2019; 28(11):2619-2628.

PMID: 31506765 DOI: 10.1007/s00586-019-06139-2.


Comparison of once-weekly teriparatide and alendronate against new osteoporotic vertebral fractures at week 12.

Ikeda S, Nakamura E, Narusawa K, Fukuda F, Matsumoto H, Nakai K J Bone Miner Metab. 2019; 38(1):44-53.

PMID: 31297652 DOI: 10.1007/s00774-019-01023-x.